Novartis
NVS
816 hedge funds and large institutions have $20.5B invested in Novartis in 2013 Q4 according to their latest regulatory filings, with 108 funds opening new positions, 287 increasing their positions, 284 reducing their positions, and 41 closing their positions.
163% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 41
36% more call options, than puts
Call options by funds: $182M | Put options by funds: $134M
12% more capital invested
Capital invested by funds: $18.4B → $20.5B (+$2.13B)
7% more funds holding
Funds holding: 761 → 816 (+55)
1% more repeat investments, than reductions
Existing positions increased: 287 | Existing positions reduced: 284
0.62% more ownership
Funds ownership: 9.88% → 10.5% (+0.62%)
5% less funds holding in top 10
Funds holding in top 10: 55 → 52 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBHC
Brown Brothers Harriman & Co
New York
|
+$890M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
+$179M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$175M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$59.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$56.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$137M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$43.1M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$42.3M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$41.6M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$31.5M |
NVS Hedge Fund Activity: Q4 2013 in Review
816 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q4 2013, worth a combined $20.5B — up 12% from $18.4B a quarter earlier.
Buyers outnumbered sellers: 108 funds opened new NVS positions and 41 closed out — a net gain of 67 holders — while 287 added to existing stakes and 284 trimmed.
The largest buyer was Brown Brothers Harriman & Co, adding an estimated $890M. The largest seller was Neuberger Berman Group, cutting an estimated $137M.
- 816 institutional investors held Novartis (NVS) as of Q4 2013, up from 761 in Q3 2013.
- Funds reported $20.5B of Novartis stock for Q4 2013, up 12% quarter-over-quarter.
- 108 funds opened new Novartis positions in Q4 2013 and 41 closed out, a net change of +67 holders.
- The largest Novartis buyer in Q4 2013 was Brown Brothers Harriman & Co, an estimated $890M added.
- The largest Novartis seller in Q4 2013 was Neuberger Berman Group, an estimated $137M sold.
Based on aggregated 13F filings for Q4 2013.